The weekly litigation news digest is live. Subscribe now

IP Verse

Pharmaceutical Compositions For Combination Therapy - EP3253382

The patent EP3253382 was granted to Intercept Pharmaceuticals on Nov 17, 2021. The application was originally filed on Feb 5, 2016 under application number EP16747312A. The patent is currently recorded with a legal status of "Revoked".

EP3253382

INTERCEPT PHARMACEUTICALS
Application Number
EP16747312A
Filing Date
Feb 5, 2016
Status
Revoked
Apr 21, 2023
Publication Date
Nov 17, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STADA ARZNEIMITTELAug 11, 2022HAMM & WITTKOPPADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2006252670
INTERNATIONAL-SEARCH-REPORTUS2007203155
INTERNATIONAL-SEARCH-REPORTUS2008096921
INTERNATIONAL-SEARCH-REPORTUS2009105343
INTERNATIONAL-SEARCH-REPORTUS2014371190
OPPOSITIONWO2006122977
SEARCHWO2006044391
SEARCHWO2014184271

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents